These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11925838)

  • 21. Decreasing self-reported cognitive biases and increasing clinical insight through meta-cognitive training in patients with chronic schizophrenia.
    Gawęda Ł; Krężołek M; Olbryś J; Turska A; Kokoszka A
    J Behav Ther Exp Psychiatry; 2015 Sep; 48():98-104. PubMed ID: 25775947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further evidence for the efficacy of a metacognitive group training in schizophrenia.
    Moritz S; Kerstan A; Veckenstedt R; Randjbar S; Vitzthum F; Schmidt C; Heise M; Woodward TS
    Behav Res Ther; 2011 Mar; 49(3):151-7. PubMed ID: 21276962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The metacognitive training for schizophrenia patients: description of method and experiences from clinical practice].
    Gaweda Ł; Moritz S; Kokoszka A
    Psychiatr Pol; 2009; 43(6):683-92. PubMed ID: 20209880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention.
    Moritz S; Woodward TS
    Curr Opin Psychiatry; 2007 Nov; 20(6):619-25. PubMed ID: 17921766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of cognitive intervention for voice hearers.
    England M
    Perspect Psychiatr Care; 2008 Jan; 44(1):40-7. PubMed ID: 18177277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Befriending patients with medication-resistant schizophrenia: can psychotic symptoms predict treatment response?
    Samarasekera N; Kingdon D; Siddle R; O'Carroll M; Scott JL; Sensky T; Barnes TR; Turkington D
    Psychol Psychother; 2007 Mar; 80(Pt 1):97-106. PubMed ID: 17346383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive therapy for schizophrenia in remission.
    Jacobs LI
    Curr Psychiatr Ther; 1982; 21():93-100. PubMed ID: 7160222
    [No Abstract]   [Full Text] [Related]  

  • 28. Cognitive approaches to schizophrenia: theory and therapy.
    Beck AT; Rector NA
    Annu Rev Clin Psychol; 2005; 1():577-606. PubMed ID: 17716100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of unilateral E.C.T. on schizophrenic delusions and hallucinations.
    el-Islam MF; Ahmed SA; Erfan ME
    Br J Psychiatry; 1970 Oct; 117(539):447-8. PubMed ID: 5481209
    [No Abstract]   [Full Text] [Related]  

  • 30. [Schizophrenic syndromes and efficacy of unilateral electroconvulsive therapy].
    Kornetov AN; Samokhvalov VP; Ovsiankin MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):249-54. PubMed ID: 3984612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of cognitive behavior therapy with a normalizing rationale in schizophrenia. Preliminary report.
    Kingdon DG; Turkington D
    J Nerv Ment Dis; 1991 Apr; 179(4):207-11. PubMed ID: 2007891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive behavior therapy for psychosis: where have we been and where are we going?
    Velligan DI
    Schizophr Bull; 2009 Sep; 35(5):857-8. PubMed ID: 19617356
    [No Abstract]   [Full Text] [Related]  

  • 33. [Progress in the development of new generation antipsychotic agents and cognitive behavior therapy for patients with schizophrenia].
    Ikebuchi H
    Seishin Shinkeigaku Zasshi; 2001; 103(12):1022-9. PubMed ID: 11925839
    [No Abstract]   [Full Text] [Related]  

  • 34. A case study: schizophrenia and tactile hallucinations, treated with electroconvulsive therapy.
    Salama AA; England RD
    Can J Psychiatry; 1990 Feb; 35(1):86-7. PubMed ID: 2317740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of schizophrenic patients and the outcome of fluphenazine and of electroconvulsive treatments.
    Landmark J; Joseph L; Merskey H
    Can J Psychiatry; 1987 Aug; 32(6):425-8. PubMed ID: 3690470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individual cognitive-behavior therapy in the treatment of hallucinations and delusions: a review.
    Haddock G; Tarrier N; Spaulding W; Yusupoff L; Kinney C; McCarthy E
    Clin Psychol Rev; 1998 Nov; 18(7):821-38. PubMed ID: 9827323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schizophrenia, the pervasive psychosis: paradoxes and empathy.
    Giovacchini PL
    J Am Acad Psychoanal; 1993; 21(4):549-65. PubMed ID: 8138459
    [No Abstract]   [Full Text] [Related]  

  • 38. Insights into hallucinations in schizophrenia: novel treatment approaches.
    Aleman A; Larøi F
    Expert Rev Neurother; 2011 Jul; 11(7):1007-15. PubMed ID: 21721917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eight-month intensive meditation-based intervention improves refractory hallucinations and delusions and quality of life in male inpatients with schizophrenia: a randomized controlled trial.
    Xue T; Sheng J; Gao H; Gu Y; Dai J; Yang X; Peng H; Gao H; Lu R; Shen Y; Wang L; Wang L; Shi Y; Li Z; Cui D
    Psychiatry Clin Neurosci; 2024 Apr; 78(4):248-258. PubMed ID: 38318694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive and affective perspectives on formation and maintenance of grandiose delusions of a patient with schizophrenia.
    Lai DC; Chang WC; Tam WW; Hui CL; Chen EY
    East Asian Arch Psychiatry; 2013 Dec; 23(4):160-3. PubMed ID: 24374488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.